Close Menu

NEW YORK – MDxHealth reported before the opening of the market on Thursday that its first quarter revenues rose 24 percent year over year, thanks to a 26 percent increase in product revenues.

For the three months ended March 31, total revenues rose to $5.9 million from $4.7 million in Q1 2019. Product revenues increased to $5.6 million from $4.5 million in the prior-year period.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A survey by Nature finds that most researchers want scientific meetings to continue virtually or with a virtual component, even after the pandemic ends.

Bloomberg reports that the B.1.351 SARS-CoV-2 viral variant could prompt the formulation of better vaccines.

Certain blood proteins may be able to distinguish COVID-19 patients who will become critically ill from those who will not, the Atlanta Journal-Constitution reports.

In Genome Biology this week: algorithm to assess regulatory features, approach to integrate multiple single-cell RNA-seq datasets, and more.